Insulin Therapy Perspective

 
 
  • DIY Artificial Pancreas: Patients Aren't Waiting for Us   Are you familiar with the DIY artificial pancreas? Drs Shubrook and Rayhan Lal discuss this growing movement.
  • Cutting Costs in Diabetes Care   The WHO issues guidelines that can be used to manage diabetes in economically disadvantaged populations.
  • Finding the Sweet Spot of Primary Care Diabetes Management   What does KISSing have to do with it? Dr Kwabena Adubofour shares his pointers for successful diabetes management.
  • Diabetes Patients Beg, Ration Insulin in Cost Crisis The high cost of insulin is driving some patients to reuse supplies and hoard insulin, with serious health implications -- sometimes even death.
  • A Clinician's Guide to the Latest Diabetes Devices With the dizzying array of new options in diabetes management and rapidly advancing CGM technology, the fingerstick may soon be obsolete.
  • Diabetes Technology Advances: It's a Whole New World for Kids   There are myriad technology advances that are making the management of diabetes in children both easier and more complicated.
  • Is One Basal Insulin Just Like Another?   A new review suggests that we may be fooling ourselves by rating one high-priced insulin over another.
  • 'Life Behind the 8-Ball': Kids With Type 2 Diabetes   Especially in underserved areas of Mississippi, children with type 2 diabetes face an uphill battle, and clinicians have to arm them appropriately for the fight.
  • 'Whatever It Takes': Helping Patients Afford Insulin   Anne Peters and Irl Hirsch discuss alternatives to pricey analog insulins.
  • Hypoglycemia, 25 Years After DCCT A new European consortium aims to help clinicians understand the underlying mechanisms and predictors of hypoglycemia in patients with type 1 diabetes.
  • Congress to Help Medicare Patients Obtain Diabetes Supplies A cost-cutting strategy adopted several years ago, called the competitive bidding program, caused access issues for many patients with diabetes; Congress is now trying to remedy the problem.
  • Formulary Snafus In an era of competing formularies and demands for preauthorization, taking a prescription to the pharmacy is often the beginning of a frustrating misadventure for patients and physicians alike.
  • Choosing Insulin: A New Wrinkle   Dr Arefa Cassoobhoy reviews a whitepaper on the affordability of insulin and how this affects treatment adherence.
  • Sometimes Doctors Need to Be Nudged A good electronic record system can help doctors remember to do what they wanted to do anyway.
  • DUPC 2018 Read clinically focused news coverage of key developments from DUPC 2018
  • SGLT2 Inhibitors in Type 1 Diabetes Are SGLT2 inhibitors safe and effective in patients with type 1 diabetes?
  • Which CGM for Which Diabetes Patient?   Dr Peters clarifies the pros and cons of the Dexcom and FreeStyle Libre continuous glucose monitors for patients with diabetes.
  • Prostate Cancer Care Is 'Changing Rapidly': ESMO 2017   Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono.
  • 'Now Is the Time to Learn' About CGM   The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.
  • Ultra-fast Insulins Curb Mealtime Spikes   Faster-acting insulins are especially beneficial for patients on continuous glucose monitors who are keeping track of glucose peaks and valleys.